RenovoRx gets U.S. patent allowance notice for RenovoCath® catheter
RenovoRx (RNXT) receives a notice of allowance for a new U.S. patent covering RenovoCath®, an advanced dual-occlusion catheter for targeted therapeutic drug-delivery in cancer treatment.